Document is current

Article History

First Online: 8 June 2020

Compliance with Ethical Standards

:

: The NIH, but not the authors of this review, reports the following disclosure statement: The National Institutes of Health holds patents on targeting JAKs. NIAMS and Pfizer have a Collaborative Research and Development Award (CRADA). However, the authors have no direct involvement in these patents or awards. Suraj Rajasimhan, Omer Pamuk, and James D. Katz have no conflicts of interest that are directly relevant to the content of this article.

: This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases.